Samsung Biologics
Samsung Biologics is a Private limited company (Ltd.) registered in South Korea, and its current status with Supreme Court Internet Registry (IROS) is active. Its registered address on file is Incheon, South Korea. 5 shareholders are on record for Samsung Biologics, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Supreme Court Internet Registry (IROS) and was last updated on 28 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for Samsung Biologics, filed with Supreme Court Internet Registry (IROS).
The largest of these is Vanguard International Stock Index-Total Intl Stock Indx, holding 13.1% — the largest recorded stake — followed by Financial Investors Tr-Seafarer Overseas Growth & Income Fd at 8.4%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 10 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard International Stock Index-Total Intl Stock Indx | 13.1% | Supreme Court Internet Registry (IROS) | |
| Financial Investors Tr-Seafarer Overseas Growth & Income Fd | 8.4% | Supreme Court Internet Registry (IROS) | |
| Fidelity Series Emerging Markets Opportunities Fund | 8.1% | Supreme Court Internet Registry (IROS) | |
| Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 7.6% | Supreme Court Internet Registry (IROS) | |
| iShares MSCI Emerging Markets Minimum Volatility Factor ETF | 2.9% | Supreme Court Internet Registry (IROS) |
Officers
5
The Executive Director of Samsung Biologics currently on record is Tae-han Kim Ph.d.; five officers are currently on record for Samsung Biologics, filed with Supreme Court Internet Registry (IROS).
The register reports 17 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Samsung Biologics sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Samsung Biologics?
Five shareholders are currently on record for Samsung Biologics, filed with Supreme Court Internet Registry (IROS). The largest of these is Vanguard International Stock Index-Total Intl Stock Indx, holding 13.1% — the largest recorded stake — followed by Financial Investors Tr-Seafarer Overseas Growth & Income Fd at 8.4%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Samsung Biologics's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Samsung Biologics is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Samsung Biologics have on record?
5 shareholders are shown on record for Samsung Biologics. The register reports 10 in total; only the top 5 by holding are shown here.
Is Samsung Biologics still an active company?
Samsung Biologics's status on Supreme Court Internet Registry (IROS) is listed as active.
What is Samsung Biologics's registered address?
The registered address on file for Samsung Biologics is Incheon, South Korea.
What legal structure is Samsung Biologics registered as?
Samsung Biologics is registered as a Private limited company (Ltd.) in South Korea.
Who are the officers/directors of Samsung Biologics?
The Executive Director of Samsung Biologics currently on record is Tae-han Kim Ph.d.; five officers are currently on record for Samsung Biologics, filed with Supreme Court Internet Registry (IROS). Management authority at Samsung Biologics sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to Samsung Biologics's ownership over time?
This profile reflects a point-in-time snapshot from Supreme Court Internet Registry (IROS). Zavia's monitoring API can track changes to Samsung Biologics's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Samsung Biologics's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including South Korea, so records like Samsung Biologics's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Supreme Court Internet Registry (IROS) and was last synced on 28 September 2026.